title: Imatinib-induced Stevens-Johnson syndrome: recurrence after re-challenge with a lower dose.
authors.forename: Manoranjan
authors.initials: M
authors.lastname: Mahapatra
authors.forename: Pravas
authors.initials: P
authors.lastname: Mishra
authors.forename: Rajat
authors.initials: R
authors.lastname: Kumar
mesh_terms: D001549:Benzamides; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D012008:Recurrence; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate